nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—Methotrexate—psoriatic arthritis	0.228	0.248	CbGbCtD
Metyrapone—CYP2A6—Prednisolone—psoriatic arthritis	0.214	0.232	CbGbCtD
Metyrapone—CYP2A6—Dexamethasone—psoriatic arthritis	0.126	0.137	CbGbCtD
Metyrapone—CYP2E1—Dexamethasone—psoriatic arthritis	0.0833	0.0904	CbGbCtD
Metyrapone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0667	0.0724	CbGbCtD
Metyrapone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0506	0.0549	CbGbCtD
Metyrapone—CYP3A4—Betamethasone—psoriatic arthritis	0.0434	0.0471	CbGbCtD
Metyrapone—CYP3A4—Prednisolone—psoriatic arthritis	0.0428	0.0465	CbGbCtD
Metyrapone—CYP3A4—Prednisone—psoriatic arthritis	0.0404	0.0439	CbGbCtD
Metyrapone—CYP3A4—Dexamethasone—psoriatic arthritis	0.0252	0.0274	CbGbCtD
Metyrapone—Adrenal insufficiency—Prednisone—psoriatic arthritis	0.00632	0.0799	CcSEcCtD
Metyrapone—Pancytopenia—Auranofin—psoriatic arthritis	0.0034	0.0431	CcSEcCtD
Metyrapone—Hirsutism—Prednisolone—psoriatic arthritis	0.00313	0.0397	CcSEcCtD
Metyrapone—Hirsutism—Triamcinolone—psoriatic arthritis	0.00288	0.0365	CcSEcCtD
Metyrapone—Hirsutism—Methylprednisolone—psoriatic arthritis	0.00288	0.0364	CcSEcCtD
Metyrapone—Hirsutism—Dexamethasone—psoriatic arthritis	0.00262	0.0331	CcSEcCtD
Metyrapone—Hirsutism—Betamethasone—psoriatic arthritis	0.00262	0.0331	CcSEcCtD
Metyrapone—Alopecia—Auranofin—psoriatic arthritis	0.00254	0.0321	CcSEcCtD
Metyrapone—Dermatitis atopic—Prednisolone—psoriatic arthritis	0.00246	0.0311	CcSEcCtD
Metyrapone—Hirsutism—Prednisone—psoriatic arthritis	0.00228	0.0288	CcSEcCtD
Metyrapone—Dermatitis atopic—Triamcinolone—psoriatic arthritis	0.00226	0.0286	CcSEcCtD
Metyrapone—Dermatitis atopic—Prednisone—psoriatic arthritis	0.00179	0.0226	CcSEcCtD
Metyrapone—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00167	0.0211	CcSEcCtD
Metyrapone—Bone marrow depression—Methotrexate—psoriatic arthritis	0.00164	0.0207	CcSEcCtD
Metyrapone—Abdominal pain—Auranofin—psoriatic arthritis	0.00161	0.0204	CcSEcCtD
Metyrapone—Endocrine disorder—Prednisone—psoriatic arthritis	0.0016	0.0202	CcSEcCtD
Metyrapone—Vomiting—Auranofin—psoriatic arthritis	0.0013	0.0164	CcSEcCtD
Metyrapone—Nausea—Auranofin—psoriatic arthritis	0.00121	0.0153	CcSEcCtD
Metyrapone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000762	0.00964	CcSEcCtD
Metyrapone—Angiopathy—Dexamethasone—psoriatic arthritis	0.000693	0.00876	CcSEcCtD
Metyrapone—Angiopathy—Betamethasone—psoriatic arthritis	0.000693	0.00876	CcSEcCtD
Metyrapone—Hypertension—Prednisolone—psoriatic arthritis	0.000688	0.0087	CcSEcCtD
Metyrapone—Alopecia—Dexamethasone—psoriatic arthritis	0.000675	0.00854	CcSEcCtD
Metyrapone—Alopecia—Betamethasone—psoriatic arthritis	0.000675	0.00854	CcSEcCtD
Metyrapone—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000665	0.00842	CcSEcCtD
Metyrapone—Pancytopenia—Methotrexate—psoriatic arthritis	0.000659	0.00834	CcSEcCtD
Metyrapone—Hypertension—Triamcinolone—psoriatic arthritis	0.000632	0.008	CcSEcCtD
Metyrapone—Hypertension—Methylprednisolone—psoriatic arthritis	0.000631	0.00798	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000618	0.00782	CcSEcCtD
Metyrapone—Angiopathy—Prednisone—psoriatic arthritis	0.000603	0.00763	CcSEcCtD
Metyrapone—Alopecia—Prednisone—psoriatic arthritis	0.000587	0.00743	CcSEcCtD
Metyrapone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000585	0.0074	CcSEcCtD
Metyrapone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000579	0.00733	CcSEcCtD
Metyrapone—Hypertension—Dexamethasone—psoriatic arthritis	0.000574	0.00726	CcSEcCtD
Metyrapone—Hypertension—Betamethasone—psoriatic arthritis	0.000574	0.00726	CcSEcCtD
Metyrapone—Hypotension—Methylprednisolone—psoriatic arthritis	0.000557	0.00705	CcSEcCtD
Metyrapone—Pain—Prednisolone—psoriatic arthritis	0.000556	0.00703	CcSEcCtD
Metyrapone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000532	0.00673	CcSEcCtD
Metyrapone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000532	0.00673	CcSEcCtD
Metyrapone—Pain—Triamcinolone—psoriatic arthritis	0.000511	0.00647	CcSEcCtD
Metyrapone—Hypotension—Betamethasone—psoriatic arthritis	0.000507	0.00641	CcSEcCtD
Metyrapone—Hypotension—Dexamethasone—psoriatic arthritis	0.000507	0.00641	CcSEcCtD
Metyrapone—Angiopathy—Methotrexate—psoriatic arthritis	0.000504	0.00638	CcSEcCtD
Metyrapone—Hypertension—Prednisone—psoriatic arthritis	0.0005	0.00632	CcSEcCtD
Metyrapone—Alopecia—Methotrexate—psoriatic arthritis	0.000491	0.00621	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000489	0.00619	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000488	0.00617	CcSEcCtD
Metyrapone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000471	0.00597	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000468	0.00592	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000468	0.00592	CcSEcCtD
Metyrapone—Pain—Dexamethasone—psoriatic arthritis	0.000464	0.00587	CcSEcCtD
Metyrapone—Pain—Betamethasone—psoriatic arthritis	0.000464	0.00587	CcSEcCtD
Metyrapone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000463	0.00586	CcSEcCtD
Metyrapone—Skin disorder—Prednisone—psoriatic arthritis	0.000459	0.00581	CcSEcCtD
Metyrapone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000444	0.00561	CcSEcCtD
Metyrapone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000444	0.00561	CcSEcCtD
Metyrapone—Dizziness—Prednisolone—psoriatic arthritis	0.00043	0.00544	CcSEcCtD
Metyrapone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000429	0.00543	CcSEcCtD
Metyrapone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000429	0.00543	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000409	0.00517	CcSEcCtD
Metyrapone—Headache—Prednisolone—psoriatic arthritis	0.000407	0.00515	CcSEcCtD
Metyrapone—Dizziness—Triamcinolone—psoriatic arthritis	0.000395	0.005	CcSEcCtD
Metyrapone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000394	0.00499	CcSEcCtD
Metyrapone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000387	0.0049	CcSEcCtD
Metyrapone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000386	0.00489	CcSEcCtD
Metyrapone—Nausea—Prednisolone—psoriatic arthritis	0.000386	0.00489	CcSEcCtD
Metyrapone—Skin disorder—Methotrexate—psoriatic arthritis	0.000383	0.00485	CcSEcCtD
Metyrapone—Vomiting—Triamcinolone—psoriatic arthritis	0.00038	0.00481	CcSEcCtD
Metyrapone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000379	0.0048	CcSEcCtD
Metyrapone—Headache—Triamcinolone—psoriatic arthritis	0.000374	0.00474	CcSEcCtD
Metyrapone—Headache—Methylprednisolone—psoriatic arthritis	0.000374	0.00473	CcSEcCtD
Metyrapone—Abdominal pain—Prednisone—psoriatic arthritis	0.000373	0.00472	CcSEcCtD
Metyrapone—Hypotension—Methotrexate—psoriatic arthritis	0.000369	0.00467	CcSEcCtD
Metyrapone—Dizziness—Betamethasone—psoriatic arthritis	0.000359	0.00454	CcSEcCtD
Metyrapone—Dizziness—Dexamethasone—psoriatic arthritis	0.000359	0.00454	CcSEcCtD
Metyrapone—Nausea—Triamcinolone—psoriatic arthritis	0.000355	0.00449	CcSEcCtD
Metyrapone—Nausea—Methylprednisolone—psoriatic arthritis	0.000354	0.00448	CcSEcCtD
Metyrapone—Vomiting—Dexamethasone—psoriatic arthritis	0.000345	0.00436	CcSEcCtD
Metyrapone—Vomiting—Betamethasone—psoriatic arthritis	0.000345	0.00436	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000341	0.00431	CcSEcCtD
Metyrapone—Headache—Betamethasone—psoriatic arthritis	0.00034	0.0043	CcSEcCtD
Metyrapone—Headache—Dexamethasone—psoriatic arthritis	0.00034	0.0043	CcSEcCtD
Metyrapone—Pain—Methotrexate—psoriatic arthritis	0.000338	0.00427	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000323	0.00408	CcSEcCtD
Metyrapone—Nausea—Betamethasone—psoriatic arthritis	0.000322	0.00408	CcSEcCtD
Metyrapone—Nausea—Dexamethasone—psoriatic arthritis	0.000322	0.00408	CcSEcCtD
Metyrapone—Dizziness—Prednisone—psoriatic arthritis	0.000312	0.00395	CcSEcCtD
Metyrapone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000312	0.00395	CcSEcCtD
Metyrapone—Vomiting—Prednisone—psoriatic arthritis	0.0003	0.0038	CcSEcCtD
Metyrapone—Headache—Prednisone—psoriatic arthritis	0.000296	0.00374	CcSEcCtD
Metyrapone—Nausea—Prednisone—psoriatic arthritis	0.000281	0.00355	CcSEcCtD
Metyrapone—Dizziness—Methotrexate—psoriatic arthritis	0.000261	0.0033	CcSEcCtD
Metyrapone—Vomiting—Methotrexate—psoriatic arthritis	0.000251	0.00318	CcSEcCtD
Metyrapone—Headache—Methotrexate—psoriatic arthritis	0.000247	0.00313	CcSEcCtD
Metyrapone—Nausea—Methotrexate—psoriatic arthritis	0.000234	0.00297	CcSEcCtD
